TRIM26 E3 ligase role has been demonstrated in limiting the lung cancer growth, by downregulating Bcl-2 suggesting a potential therapeutic role in cancer treatment (Yi et al., 2016; Figure 3). Here, BCL2 is linked to lung carcinoma.